mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.008 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.009 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |